Concepedia

Jake S. O’Donnell

JS

Statistics

Publications

11

Citations

1.9K

H-Index

11

Active since

2016

Affiliations

The University of Queensland(Current)

QIMR Berghofer Medical Research Institute

The University of Sydney

Royal Prince Alfred Hospital

Melanoma Institute Australia

Jake S. O’Donnell is an author at The University of Queensland specializing in oncology, immunology, and cancer immunotherapy.

ORCID

Publications per year

2016–2022

11

Publications

11

Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease

Jing Liu, Stephen J. Blake, Michelle C.R. Yong et al. · Cancer Discovery · 2016 · 864 citations

, , +15

Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy

Nicole Glodde, Tobias Bald, Debby van den Boorn-Konijnenberg et al. · Immunity · 2017 · 274 citations · Full text

, , +12

Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies

Hui Yi Chew, Priscila Oliveira de Lima, Jazmina L. Gonzalez Cruz et al. · Cell · 2020 · 187 citations

, , +9

Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome

Jing Liu, Jake S. O’Donnell, Juming Yan et al. · OncoImmunology · 2019 · 114 citations · Full text

, , +17

Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma

Ailin Lepletier, Jason Madore, Jake S. O’Donnell et al. · Clinical Cancer Research · 2020 · 112 citations · Full text

, , +17

1–5 of 11